Form 4 for RMD ResMed|
Accepted 2024-11-27 00:00:00 ET · period of report 2024-11-25 · accession 0001127602-24-028165 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2024-11-27 | 2024-11-27 | RMD | Farrell Michael J. | CEO | G - Gift | $0.00 | 0 | 2,000 | New | $0 |
| DI | 2024-11-27 | 2024-11-27 | RMD | Farrell Michael J. | CEO | S - Sale | $249.67 | -2,000 | 0 | -100% | -$499.3K |
| D | 2024-11-27 | 2024-11-25 | RMD | Farrell Michael J. | CEO | A - Grant | $249.56 | +33.0K | 33.0K | New | +$8.24M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ResMed Common Stock | 2024-11-27 | G | D | 2,000 | $0.00 | 2,090 | I Lisette and Michael Farrell Family Trust | — | — | |
| 2 | Common | ResMed Common Stock | 2024-11-27 | G | A | 2,000 | $0.00 | 2,000 | I Lisette and Michael Farrell Foundation | — | — | |
| 3 | Common | ResMed Common Stock | 2024-11-27 | S | D | 2,000 | $249.67 | 0 | I Lisette and Michael Farrell Foundation | — | — | |
| 4 | Derivative | ResMed Common Stock Options | 2024-11-25 | A | A | 33,036 | $249.56 | 33,036 | D | $249.56 · 2025-11-11 to 2031-11-25 | 33,036 ResMed Common Stock | (F3) Represents date options first become exercisable. Options vest 1/3 per year. |